{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05375084",
            "orgStudyIdInfo": {
                "id": "NAV-1004"
            },
            "organization": {
                "fullName": "Navire Pharma Inc., a BridgeBio company",
                "class": "INDUSTRY"
            },
            "briefTitle": "SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation",
            "officialTitle": "A Phase 1 Study of the SHP2 Inhibitor BBP-398 (Formerly Known as IACS-15509) in Combination With the Programmed Death Receptor-1 Blocking Antibody Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "inhibitor-bbp-in-combination-with-nivolumab-in-patients-with-advanced-non-small-cell-lung-cancer-with-a-kras-mutation"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-10-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-10",
            "studyFirstSubmitQcDate": "2022-05-10",
            "studyFirstPostDateStruct": {
                "date": "2022-05-16",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-14",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Navire Pharma Inc., a BridgeBio company",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "Bristol-Myers Squibb",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 1 study of BBP-398, a SHP2 inhibitor, in combination with nivolumab, a PD-1 antibody, in patients with NSCLC with a KRAS mutation. The study involves 2 parts: Phase 1a Dose Escalation and Phase 1b Dose Expansion.",
            "detailedDescription": "The primary objective for Phase 1a Dose Escalation is to evaluate the safety, tolerability, and RP2D of BBP-398, a SHP2 inhibitor, when used in combination with nivolumab in patients with advanced NSCLC with a KRAS mutation who have failed standard of care treatment.\n\nThe primary objective for Phase 1b Dose Expansion is to evaluate the antitumor activity of BBP-398, as defined by the ORR (per investigator) according to RECIST v1.1, when used in combination with nivolumab in patients with advanced NSCLC with a KRAS mutation who have failed standard of care treatment."
        },
        "conditionsModule": {
            "conditions": [
                "Non Small Cell Lung Cancer",
                "Solid Tumor"
            ],
            "keywords": [
                "KRAS mutation",
                "MAPK-pathway alterations",
                "NSCLC",
                "SHP2"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 45,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Dose Escalation Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "Level 1 oral capsules administered in combination with nivolumab",
                    "interventionNames": [
                        "Drug: BBP-398 with nivolumab"
                    ]
                },
                {
                    "label": "Dose Escalation Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "Level 2 oral capsules administered in combination with nivolumab",
                    "interventionNames": [
                        "Drug: BBP-398 with nivolumab"
                    ]
                },
                {
                    "label": "Dose Escalation Level 3",
                    "type": "EXPERIMENTAL",
                    "description": "Level 3 oral capsules administered in combination with nivolumab",
                    "interventionNames": [
                        "Drug: BBP-398 with nivolumab"
                    ]
                },
                {
                    "label": "Dose Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "RP2D defined dose. Oral capsules administered in combination with nivolumab",
                    "interventionNames": [
                        "Drug: BBP-398 with nivolumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "BBP-398 with nivolumab",
                    "description": "BBP-398 administered orally once a day (QD); nivolumab administered intravenously every 4 weeks (Q4wks)",
                    "armGroupLabels": [
                        "Dose Escalation Level 1",
                        "Dose Escalation Level 2",
                        "Dose Escalation Level 3",
                        "Dose Expansion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1a Dose Escalation: Assess safety, tolerability, and recommended phase 2 dose (RP2D) of BBP-398 in combination with nivolumab",
                    "timeFrame": "Completion of 1 Cycle (28 days)"
                },
                {
                    "measure": "Phase 1b Dose Expansion: Assess antitumor activity of BBP-398 in combination with nivolumab",
                    "description": "Anti-tumor activity will be defined by objective response rate (ORR) according to RECIST v1.1",
                    "timeFrame": "Completion of 1 Cycle (28 days)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Assess preliminary antitumor activity of BBP-398 in combination with nivolumab",
                    "description": "Anti-tumor activity will be defined by objective response rate (ORR) \\[escalation\\], duration of response (DOR) and progression free survival (PFS), as defined by RECIST v1.1. and overall survival (OS) \\[both escalation and expansion\\]",
                    "timeFrame": "Completion of 1 Cycle (28 days)"
                },
                {
                    "measure": "Phase 1b Dose Expansion: Assess safety and tolerability of BBP-398 at the RP2D, in combination with nivolumab",
                    "timeFrame": "Completion of 1 Cycle (28 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Patients must have histologically documented, locally advanced and unresectable, or metastatic NSCLC with documentation of a KRAS mutation within the 1 year prior to screening.\n* Patients must have measurable disease by RECIST v1.1.\n* Patients must have a minimum life expectancy of \\>12 weeks after start of study treatment.\n* Patients must have progression or disease recurrence on or after at least one prior line of systemic therapy, which must include platinum-based doublet chemotherapy and anti-PD-(L)1 therapy.\n* Patients must have experienced progressive or recurrent disease occurring either during treatment or within 90 days after discontinuing anti-PD-(L)1 therapy.\n* Patients must have an Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1.\n* Patients must have adequate organ function.\n\nKey Exclusion Criteria:\n\n* Patients that have participated in an interventional clinical study within the last 4 weeks.\n* Patients that have received radiotherapy or proton therapy with a limited field of radiation for palliation within 1 week of the start of study treatment, OR radiation to more than 30% of the bone marrow or with a wide field of radiation within 4 weeks of the start of study treatment.\n* Patients with known central nervous system (CNS) tumors or active CNS metastases.\n* Patients that have experienced progressive disease (PD) within the first 120 days of initiating treatment with an anti- PD-(L)1 agent (e.g., primary refractory).\n* Patients that have a history of allogenic bone marrow transplant.\n* Patients that have select known or suspected autoimmune disease.\n* Patients that have a condition requiring systemic treatment with either corticosteroids (\\>10 mg prednisone equivalent) or other immunosuppressive medication within 14 days of study start.\n* Patients that have received any live/attenuated vaccine within 30 days of first study treatment.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Navire Clinical Operations",
                    "role": "CONTACT",
                    "phone": "650-391-9740",
                    "email": "NAV1004ct.gov@bridgebio.com"
                }
            ],
            "locations": [
                {
                    "facility": "Highlands Oncology",
                    "status": "RECRUITING",
                    "city": "Springdale",
                    "state": "Arkansas",
                    "zip": "72762",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Allie Clemons",
                            "role": "CONTACT",
                            "phone": "479-872-8130",
                            "email": "research@hogonc.com"
                        },
                        {
                            "name": "Eric S Schaefer, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.18674,
                        "lon": -94.12881
                    }
                },
                {
                    "facility": "Scripps Clinic Torrey Pines",
                    "status": "RECRUITING",
                    "city": "La Jolla",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kiley Borchard, CCRC",
                            "role": "CONTACT",
                            "email": "crs_leadership_research@scrippshealth.org"
                        },
                        {
                            "name": "Michael Kosty, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84727,
                        "lon": -117.2742
                    }
                },
                {
                    "facility": "Providence Medical Foundation",
                    "status": "RECRUITING",
                    "city": "Santa Rosa",
                    "state": "California",
                    "zip": "95403",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tracy Foster",
                            "role": "CONTACT",
                            "phone": "707-521-3830",
                            "email": "tracy.foster@stjoe.org"
                        },
                        {
                            "name": "Ian Anderson, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.44047,
                        "lon": -122.71443
                    }
                },
                {
                    "facility": "Memorial Regional Hospital (Memorial Cancer Institute)",
                    "status": "RECRUITING",
                    "city": "Hollywood",
                    "state": "Florida",
                    "zip": "33021",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tamara Quintana",
                            "role": "CONTACT",
                            "phone": "954-265-4325",
                            "email": "lraez@mhs.net"
                        },
                        {
                            "name": "Milton Sanchez",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Luis E Raez, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.0112,
                        "lon": -80.14949
                    }
                },
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Eduardo Galvez",
                            "role": "CONTACT",
                            "phone": "813-745-4673",
                            "email": "Eduardo.Galvez@moffitt.org"
                        },
                        {
                            "name": "Bruna Pellini, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Johns Hopkins Sidney Kimmel Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kayla Eck",
                            "role": "CONTACT",
                            "phone": "410-955-7458",
                            "email": "kmarron1@jhmi.edu"
                        },
                        {
                            "name": "Kristen Marrone, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Henry Ford Hospital",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Roswell Park Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Buffalo",
                    "state": "New York",
                    "zip": "14203",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.88645,
                        "lon": -78.87837
                    }
                },
                {
                    "facility": "Cleveland Clinic",
                    "status": "RECRUITING",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44195",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica Grebenc",
                            "role": "CONTACT",
                            "phone": "216-444-7923",
                            "email": "canceranswer@ccf.og"
                        },
                        {
                            "name": "Nathan Pennell, MD, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "Providence Portland Medical Center",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97213",
                    "country": "United States",
                    "contacts": [
                        {
                            "role": "CONTACT",
                            "email": "CanRsrchStudies@providence.org"
                        },
                        {
                            "name": "Rachel Sanborn, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "University of Pennsylvania (Abramson Cancer Center)",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Medical University of South Carolina (MUSC) - Hollings Cancer Center",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29425",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lamiae Sahnoune",
                            "role": "CONTACT",
                            "phone": "832-729-2342",
                            "email": "Lsahnoune@mdanderson.org"
                        },
                        {
                            "name": "Marcelo V Negrao",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Millennium Research and Clinical Development",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77090",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "NEXT Oncology",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Blake Patterson",
                            "role": "CONTACT",
                            "phone": "703-783-4510",
                            "email": "bpatterson@nextoncology.com"
                        },
                        {
                            "name": "Alex Spira",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008175",
                    "term": "Lung Neoplasms"
                },
                {
                    "id": "D000002289",
                    "term": "Carcinoma, Non-Small-Cell Lung"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012142",
                    "term": "Respiratory Tract Neoplasms"
                },
                {
                    "id": "D000013899",
                    "term": "Thoracic Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008171",
                    "term": "Lung Diseases"
                },
                {
                    "id": "D000012140",
                    "term": "Respiratory Tract Diseases"
                },
                {
                    "id": "D000002283",
                    "term": "Carcinoma, Bronchogenic"
                },
                {
                    "id": "D000001984",
                    "term": "Bronchial Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "asFound": "Non-small Cell Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "asFound": "Lung Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6845",
                    "name": "Death",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M14979",
                    "name": "Respiratory Tract Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16658",
                    "name": "Thoracic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11168",
                    "name": "Lung Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14977",
                    "name": "Respiratory Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5540",
                    "name": "Carcinoma, Bronchogenic",
                    "relevance": "LOW"
                },
                {
                    "id": "M5260",
                    "name": "Bronchial Neoplasms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000077594",
                    "term": "Nivolumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4225",
                    "name": "Antibodies",
                    "relevance": "LOW"
                },
                {
                    "id": "M1854",
                    "name": "Nivolumab",
                    "asFound": "Technique",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10184",
                    "name": "Immunoglobulins",
                    "relevance": "LOW"
                },
                {
                    "id": "M21134",
                    "name": "Antibodies, Blocking",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                }
            ]
        }
    },
    "hasResults": false
}